# Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

> **NCT02532517** · NA · TERMINATED · sponsor: **Cerenovus, Part of DePuy Synthes Products, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DEVICE:** CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System

## Key facts

- **NCT ID:** NCT02532517
- **Lead sponsor:** Cerenovus, Part of DePuy Synthes Products, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-01
- **Primary completion:** 2019-01-08
- **Final completion:** 2019-09-21
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** No safety issues; change in innovation strategy
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532517, "Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02532517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*